No Image Available

Aminoamino Acids Infusion 8% W/v

Form: Solution for IV infusion

Strength: 8 g per 100 mL (i.e., 80 g/L)

Reference Brands: Aminoplasmal 8%(EU); Aminomix 8%(India)

Category: Critical Care

Amino Acids Infusion 8% w/v is a sterile intravenous solution formulated for parenteral nutrition in patients unable to eat or absorb nutrients orally. It contains a balanced mix of essential and non-essential amino acids, supporting protein synthesis, tissue repair, and nitrogen balance. This formulation is commonly used in hospitals and critical care settings for patients recovering from surgery, trauma, sepsis, or malnutrition. Administered alongside dextrose and lipid infusions, it forms a key component of total parenteral nutrition (TPN). Available in flexible infusion bags or glass bottles, it is an essential product for clinical nutrition and hospital supply chains.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.